A
Adaptam Therapeutics
Raised $3.5M in a Pre-Seed round, announced 27 October 2025.
Round
$3.5MPre-Seed, 27 October 2025
Funds advance lead antibody programs toward preclinical development.
- Amount
- $3.5M
- Stage
- Pre-Seed
- Announced
- 27 October 2025
- Lead
- Criteria Bio Ventures
- Use of funds
- Funds advance lead antibody programs toward preclinical development.
- Checked
- Amount and date checked against the press source
- Source
- Adaptam Therapeutics raises €3M techfundingnews.com
Company
Antibody-based cancer immunotherapies targeting glyco-immune checkpoints on myeloid cells
- Based in
- 🇪🇸Spain
- Sector
- Health
Questions
How much has Adaptam Therapeutics raised?
Adaptam Therapeutics raised $3.5M in a Pre-Seed round, announced on 27 October 2025.
Who invested in Adaptam Therapeutics?
Criteria Bio Ventures led. Investors include Criteria Bio Ventures.
